Severe Aortic Stenosis: Stratifying Patients for Lifetime Management

Published: 12 April 2022

  • Views:

    Views Icon 777
  • Likes:

    Heart Icon 7


Full programme

Part 3 of 3

SAVR or TAVI First in Younger Candidates: A Question of Hypotheticals?

Rebecca T Hahn, Thomas Modine, David Wood, Victoria Delgado


In this symposium, part of the Transcatheter Interventions Online 2022, the faculty consider when to use a surgery or TAVI-first approach, summarise clinical evidence to date and assess possible management scenarios by way of clinical cases.


The symposium consists of three presentations followed by a faculty discussion.


Note, this on-demand version is not CME accredited. 



This symposium has been supported by an unrestricted educational grant by Edwards LifeSciences.

Key Learning Objectives

  • Describe the challenges with lifetime management in severe AS in both a SAVR and TAVI-first scenario
  • Summarise clinical evidence for TAVI in low surgical risk patients
  • Recall different guideline recommendations for SAVR and TAVI approaches
  • Assimilate current clinical knowledge with patient preferences when formulating treatment plans for severe AS patient

Target Audience

  • Interventional cardiologists
  • Surgeons with an interest in transcatheter treatment strategies for coronary and structural heart disease
  • Interventional cardiology nurses

More from this programme

Part 1

Forward Planning in Severe AS

In the opening chapter, Dr David Wood begins the symposium by providing a short outline on the updated guidelines, the considerations for long term management including age patient preferences. Dr David Wood closes his with hemoynamics and durability by providing an oversight into the process physicians are following with COMPLETE TAVR and DISCORDANCE TAVR.

Part 2

SAVR vs TAVI in Younger Patients - What do the Clinical Data tell us?

Dr Victoria Delgado dives into the data and clinical data physicians have, and touches on the history and the rise of TAVI with low-risk and high-risk patients.

Part 3

SAVR or TAVI First in Younger Candidates: A Question of Hypotheticals?

In the final chapter, Dr Rebecca Hahn presents a provocative patient case study. The chapter concludes with Dr Hahn asking the faculty important questions, and provides a series of scenarios for the panel to discuss.

Faculty Biographies

Rebecca T Hahn

Rebecca T Hahn

Director of Interventional Echocardiography

Rebecca T Hahn is Director of Interventional Echocardiography at NewYork-Presbyterian/ Columbia University Medical Center, US. She also serves as Professor of Clinical Medicine at Columbia College of Physicians and Surgeons. Dr Hahn completed her medical training at University of Washington School of Medicine, and her residency and fellowship at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. Dr Hahn is board certified in cardiovascular disease, internal medicine and echocardiography.

View full profile
Thomas Modine

Thomas Modine

Cardiovascular and Thoracic Surgeon

Thomas Modine graduated from Lille University Hospital, France. He has MD, PhD and MBA degrees and is a renowned surgeon in TAVI, TMVR, minimally invasive surgery and valve sparing techniques. He is also involved in basic science research programmes and is developing a percutaneous mitral programme with IP. From 2004 to 2006, Thomas completed a PhD thesis and then went on to complete a 1-and-a-half-year fellowship at Harefield Hospital, London. Later he dedicated his training to the development and progress of percutaneous techniques and heart team approach. His research interests are in aortic valve complex, bioengineering, beating heart surgery, hybrid approaches, TAVI and TMVR. Both basic and clinical aspects of research experiences are studied. He is currently working as a consultant cardiac surgeon at Lille University Hospital and professor at Jiao Tong University, Shanghai.

Dr Modine is an editorial board member of Interventional Cardiology: Reviews,…

View full profile
David Wood

David Wood

Dr David Wood works as an interventional cardiologist at Vancouver General Hospital.

Dr Wood is a professor in the Department of Medicine at the University of British Columbia and a co-founding member of the Centre for Heart Valve Innovation in Vancouver.

He serves as the President of the Canadian Association of Interventional Cardiology.

View full profile
Victoria Delgado

Victoria Delgado

Victoria Delgado is a cardiologist specializing in non-invasive imaging.

In 2010 she graduated cum laude on the topic “Novel cardiac imaging technologies.” In 2005, she completed training as a cardiologist and in 2006 her interest in non-invasive imaging. Both programs she attended at the Hospital Clinic, associated with the University of Barcelona, Spain.

In 2007 she began a fellowship in “new non-invasive cardiac imaging” at the Cardiology Department at the Leiden University Medical Center. Since 2010 she has been a staff member at the Department of Cardiology of the LUMC

View full profile